about
Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas systemMulti-OMICs and Genome Editing Perspectives on Liver Cancer Signaling NetworksA Broad Overview and Review of CRISPR-Cas Technology and Stem CellsRecent Advances in Genome Editing Using CRISPR/Cas9CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseasesAn Overview of CRISPR-Based Tools and Their Improvements: New Opportunities in Understanding Plant-Pathogen Interactions for Better Crop ProtectionThe emerging role of viral vectors as vehicles for DMD gene editingNucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-newIn Vivo Delivery Systems for Therapeutic Genome EditingCustomizing the genome as therapy for the β-hemoglobinopathiesGenome Engineering with TALE and CRISPR Systems in NeuroscienceBrain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the futureNeurogenethics: An emerging discipline at the intersection of ethics, neuroscience, and genomicsThe Rise of CRISPR/Cas for Genome Editing in Stem CellsGene targeting, genome editing: from Dolly to editorsGenome-editing Technologies for Gene and Cell TherapyCRISPR/Cas9 and cancer targets: future possibilities and present challengesNuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome EditingAdvanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the BrainGenome Editing and Its Applications in Model OrganismsRevolutionizing plant biology: multiple ways of genome engineering by CRISPR/CasTowards a new era in medicine: therapeutic genome editingBeyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogationResources for the design of CRISPR gene editing experimentsApplications of CRISPR-Cas systems in neuroscienceHow specific is CRISPR/Cas9 really?Origins of Programmable Nucleases for Genome EngineeringMinimizing off-Target Mutagenesis Risks Caused by Programmable NucleasesApplication of CRISPR/Cas9 Technology to HBVA new age in functional genomics using CRISPR/Cas9 in arrayed library screeningSingle-Base Pair Genome Editing in Human Cells by Using Site-Specific EndonucleasesApplications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology ResearchEnabling functional genomics with genome engineeringCRISPR-Cas9: A Revolutionary Tool for Cancer ModellingStrategies for precision modulation of gene expression by epigenome editing: an overviewEngineered Viruses as Genome Editing DevicesDesigned nucleases for targeted genome editingUse of designer nucleases for targeted gene and genome editing in plantsThe CRISPR revolution and its impact on cancer researchMeasuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9
P2860
Q24669821-B160F36A-EE0D-47DD-8B96-33438FF5C795Q26741086-A5D88AA4-5EF1-4585-9E1B-599B862AF840Q26741371-FC04474E-7405-403D-B61D-BCAF2488100BQ26744073-A34E5B96-F2D6-433B-922B-75A244A61A4BQ26744172-CACCC631-4B99-4054-96EB-BC42F1B966F7Q26745534-9031BCE9-9A4E-44DA-B528-412958A77C95Q26746647-372D156E-6AB3-4D92-8723-C26C4AAB84ABQ26748885-EC84AC27-CE7E-47FD-AEB5-D93BA2E89120Q26748886-E5D23DCF-A4E1-4771-9125-938E776387D4Q26751061-C230F5A6-93D8-4FC1-BD4B-45BB6EB07818Q26752488-2830DBCA-6E8A-4BFD-AD46-0658C6AB3D3AQ26753206-6B0B3982-31EB-4F92-BF0A-A0594DAD3159Q26764827-C59AD8C6-FC93-4B60-BFE0-C2666144A17AQ26765852-8899DE67-3C66-4D97-B71A-CAF54FF78254Q26768799-6937D716-F84E-47E3-86D8-AEF26588CBE7Q26769662-89D77B30-5811-4C9F-94BB-F12405128A17Q26769907-92ECF6F1-4E25-485C-800D-3B23C5A2B3B8Q26770012-09A4313B-BEBB-4D38-8106-BA90E3972E84Q26770355-9802C6F9-2A37-4202-898A-38A2A61989AEQ26772108-7D501611-78ED-4DBE-8F52-3FC846D3F232Q26773013-568E1F7A-A2DD-4D08-A23A-BE798AE38585Q26773287-F107C6EB-7507-40F8-AC5E-86AF2E7C09EFQ26775746-59F44FF8-368F-4200-92AE-D7FBD32A2AF0Q26776435-20D5B458-9FF9-469A-8334-F18AF48EE897Q26776515-CA72107C-1067-476E-9D17-A494A18182D4Q26777801-DBFA5F33-0250-4E86-860B-47B80E2944BBQ26778501-5005037B-930D-4F17-AC7A-0DEE6EC8EDE5Q26778992-AA14C2B9-E062-474E-B3FB-27F477D20100Q26779150-13D17147-2D25-4486-9495-F275BDC46916Q26781135-59D4EC59-6E71-4ADB-9E41-7BC62128CF80Q26781370-E681995D-493A-449A-A308-C8E97A0DFA48Q26781399-C6B556A6-C649-4455-A745-072DC457759EQ26782747-BEB966BD-8411-44CA-8884-BF39AD875086Q26782773-8F61DDED-B09F-4514-84EB-323828C835E5Q26782876-9D6B6D4F-6B5F-422F-9115-3C76EEB72D49Q26785927-202FC6F2-C4C0-4534-95FB-0035EE69B2DBQ26787105-E51E21A6-549B-4775-8279-0AED92DD1F31Q26799592-DC0C7FAD-233F-4B8E-AFE0-F75300F26658Q26824997-BFA71355-A688-4F1D-B44F-2146F928F2F0Q27011906-D25860E8-3CD0-40A5-8495-524B9E904F53
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
In vivo genome editing using Staphylococcus aureus Cas9
@ast
In vivo genome editing using Staphylococcus aureus Cas9
@en
In vivo genome editing using Staphylococcus aureus Cas9
@nl
type
label
In vivo genome editing using Staphylococcus aureus Cas9
@ast
In vivo genome editing using Staphylococcus aureus Cas9
@en
In vivo genome editing using Staphylococcus aureus Cas9
@nl
prefLabel
In vivo genome editing using Staphylococcus aureus Cas9
@ast
In vivo genome editing using Staphylococcus aureus Cas9
@en
In vivo genome editing using Staphylococcus aureus Cas9
@nl
P2093
P2860
P50
P356
P1433
P1476
In vivo genome editing using Staphylococcus aureus Cas9
@en
P2093
Andrea J Kriz
Bernd Zetsche
David A Scott
Feng Zhang
Ophir Shalem
Phillip A Sharp
Winston X Yan
P2860
P2888
P304
P356
10.1038/NATURE14299
P407
P577
2015-04-01T00:00:00Z
P5875
P6179
1019168198